National Survey of Research Commercialisation - Australian ...

NATIONAL SURVEY OF RESEARCH COMMERCIALISATION
CSIRO
In Year 2000, CSIRO executed 168 licences. Two divisions accounted for 51% of these
licences, which were largely for licensing of software. Two divisions executed no licences.
A) EXCLUSIVIT Y PATTERNS
The survey sought information from institutions about:
the numbers of licences executed in Year 2000 that were either exclusive or nonexclusive;
and
the numbers of licences executed in Year 2000 that were executed with start-up, small,
medium or large companies.
For the purposes of this survey, companies were defined as follows:
Start-up companies were companies engaged in businesses that were dependent, for
their formation, upon licensing or assignment of technology by the institutions that
were the subject of this survey.
Small companies were companies that had 1 to 19 employees at the time of entering
into licence agreements with institutions that were the subject of this survey — small
companies did not include start-up companies.
Medium companies were companies that had 20 to 199 employees at the time of
entering into a licence agreement with institutions that were the subject of this survey.
Large companies were companies that had 200 or more employees at the time of
entering into a licence agreement with institutions that were the subject of this survey.
Of the 417 licences executed by universities, medical research institutes and CSIRO in
Year 2000, 391 (94%) were reported as either exclusive or non-exclusive. Of these 391
licences, 40% were exclusive and 60% were non-exclusive.
Table 10: Licences executed — exclusive and non-exclusive, Year 2000
(for respondents that provided data)
Total Licences
Executed
Exclusive
Percent of
Total
Non-Exclusive
Percent of
Total
Universities 208 103 50 105 50
Medical Research Institutes 15 14 93 1 7
CSIRO 168 41 24 127 76
Total 391 158 40 233 60
Of the 417 licences executed by universities, medical research institutes and CSIRO in
Year 2000, 336 (81%) were reported as being executed to start-up, small, medium or
large companies. Of these 336 licences, 18% were executed to start-up companies, 19% to
small companies, 12% to medium companies and 51% to large companies.
30